Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients. 2010

Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
Department of Cardiology, Oita Red Cross Hospital, Oita 870-0033, Japan. anan-f@med.oita-u.ac.jp

The presence of diabetic retinopathy (DR) and increased of visceral fat accumulation (VFA) are associated with high mortality in type 2 diabetes mellitus patients. This preliminary study was therefore designed to test the hypothesis that DR is associated with insulin resistance and VFA in type 2 diabetes mellitus patients without insulin treatment. A total of 102 type 2 diabetes mellitus patients were divided into 2 groups: DR group (age, 60 +/- 6 years [mean +/- SD]; n = 31) and no diabetic retinopathy (NDR) group (59 +/- 5 years, n = 71). The level of blood glucose was assessed by fasting plasma glucose, fasting immunoreactive insulin, homeostasis model assessment index, and hemoglobin A(1c). The fat distribution was evaluated by measuring the VFA by abdominal computed tomography at the umbilical level. The body mass index and waist circumference were higher in the DR group than in the NDR group (P < .001 and P < .0005, respectively). Plasma levels of triglyceride were higher, whereas high-density lipoprotein cholesterol was lower, in the DR group than in the NDR group (P < .005 and P < .0001, respectively). Fasting plasma glucose (P < .0005), insulin concentrations (P < .0001), homeostasis model assessment index (P < .0001), and VFA (P < .0001) levels were higher in the DR group than in the NDR group. Multivariate logistic analysis revealed that DR was independently predicted by high VFA and insulin resistance. The results of this preliminary study indicate that the presence of DR was associated with high VFA and insulin resistance in Japanese patients with type 2 diabetes mellitus.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D003930 Diabetic Retinopathy Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic

Related Publications

Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
October 2003, Metabolism: clinical and experimental,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
August 2018, Cardiovascular diabetology,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
September 2018, Diabetes research and clinical practice,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
January 2015, Cardiovascular diabetology,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
January 2012, International journal of endocrinology,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
June 2010, BMC research notes,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
September 2021, Gene,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
January 2023, Journal of diabetes research,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
February 2011, Diabetes research and clinical practice,
Futoshi Anan, and Takayuki Masaki, and Yuji Ito, and Takahiko Eto, and Yoshikazu Umeno, and Nobuoki Eshima, and Tetsunori Saikawa, and Hironobu Yoshimatsu
January 2014, Ophthalmic research,
Copied contents to your clipboard!